ALDH1A1 and cancer: Histologically benign tissue from patients who ultimately went on to develop cancer showed statistically significant increased cytoplasmic ALDH1 positivity compared to those who did not (Fig. 6A; 5.6 ± 1.3% compared to 23 ± 8.8%, p = 0.002).